Cambridge
AstraZeneca shores up Cambridge move
July 11, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, research and development
AstraZeneca has cemented its position in Cambridge, the UK location of its purpose-built global HQ from 2016, by signing deals …
AstraZeneca chooses Cambridge for global HQ
June 19, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, MedImmune
AstraZeneca has chosen the Cambridge Biomedical Campus on the outskirts of the city as a new research and corporate hub. …
Private equity firm pays $212m for Cambridge Major Labs
January 16, 2013Manufacturing and Production American Capital, CML, Cambridge
Private equity firm American Capital has said it will pay $212 million to buy out Cambridge Major Laboratories (CML), a …
Cambridge University gains stem cell centre funding
August 9, 2012Research and Development, Sales and Marketing Cambridge, MRC, Wellcome Trust, stem cell
The Wellcome Trust and the Medical Research Council are investing £8 million into a new stem cell research centre. The …
GSK partners with Cambridge University
June 18, 2012Research and Development, Sales and Marketing ABPI, Cambridge, GSK, R&D
The University of Cambridge begins a new collaboration with GlaxoSmithKline today to advance drug discovery and the development of new …
Mundipharma appoints Paul Medeiros as head of corporate and business development
March 6, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, Medeiros, Mundipharma
Mundipharma International has appointed Paul Medeiros as its new head of corporate and business development at its Cambridge, UK site. …
Indian firm Dr Reddy’s opens UK site
April 12, 2011Sales and Marketing Cambridge, Chirotech, Dr Reddy's, India, generics
Indian firm Dr Reddy’s has confirmed the UK is still attractive for investment as it opens its new pharma services …
Cambridge biotech – innovation and global partnerships
October 19, 2009Research and Development Cambridge, ERBI, biotech, regenerative medicine
Just two years ago it cost $10m to sequence a human genome, now for $48,000 you can have a personal …
MedImmune broadens drug discovery in Cambridge
November 13, 2008Research and Development Cambridge, MedImmune
MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
MedImmune opens new R&D facility in Cambridge
October 17, 2008Research and Development Cambridge, MedImmune
MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
